Zoctr Health Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-06-2024
- Paid Up Capital ₹ 0.18 M
as on 19-06-2024
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.00 Cr
as on 19-06-2024
- Revenue 444.54%
(FY 2022)
- Profit 18572.22%
(FY 2022)
- Ebitda 72.26%
(FY 2022)
- Net Worth 45.90%
(FY 2022)
- Total Assets -35.17%
(FY 2022)
About Zoctr Health
The Corporate was formerly known as Zyklus Biosciences Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.18 M.
The company has closed loans amounting to ₹1.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dinesh Pendharkar and Nidhi Saxena serve as directors at the Company.
- CIN/LLPIN
U74999MH2013PTC242810
- Company No.
242810
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Zoctr Health Private Limited offer?
Zoctr Health Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Facilities, Medical Consultants & Clinics, Health Care Service.
Who are the key members and board of directors at Zoctr Health?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Pendharkar  | Director | 10-Jan-2015 | Current |
| Nidhi Saxena | Director | 02-May-2013 | Current |
Financial of Zoctr Health.
Zoctr Health Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 444.54% increase. The company also saw a substantial improvement in profitability, with a 18572.22% increase in profit. The company's net worth Soared by an impressive increase of 45.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zoctr Health?
In 2022, Zoctr Health had a public holding of 46.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pswitch Healthcare Private LimitedInactive For E-Filing 9 months 19 daysDinesh Pendharkar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 May 2017 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Zoctr Health?
Zoctr Health has a workforce of 25 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zoctr Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zoctr Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
